Central nervous system depressant, analgesic and monoamine oxidase inhibitory properties of substituted piperidines.
Eight 1-(arylaminothiocarbonyl)-4-hydroxy-4-phenyl piperidines were evaluated for their central nervous system depressant, analgesic, and monoamine oxidase inhibitory properties. The central nervous system depressant property of these substituted piperidines was reflected by their ability to potentiate pentobarbital-induced sleep in mice ranging from 18.3 to 58.5 minutes. The analgesic activity possessed by these substituted piperidines, with the exception of one compound, was shown by their ability to provide 16.7 to 50 percent protection against tail pinch response in mice. All substituted piperidines (1 mM) inhibited in vitro activity of rat brain monoamine oxidase with the degree of inhibition ranging from 17.2 to 18.3 percent.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000201:enzymology; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010146:Pain / Q000188:drug therapy; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013329:Structure-Activity Relationship
D000700:Analgesics; D002492:Central Nervous System Depressants; D008996:Monoamine Oxidase Inhibitors; D010880:Piperidines